CN103989589A - 含有香豆雌酚或包含香豆雌酚的豆提取物的、用于皮肤护理的化妆品组合物 - Google Patents
含有香豆雌酚或包含香豆雌酚的豆提取物的、用于皮肤护理的化妆品组合物 Download PDFInfo
- Publication number
- CN103989589A CN103989589A CN201410243191.4A CN201410243191A CN103989589A CN 103989589 A CN103989589 A CN 103989589A CN 201410243191 A CN201410243191 A CN 201410243191A CN 103989589 A CN103989589 A CN 103989589A
- Authority
- CN
- China
- Prior art keywords
- coumestrol
- skin
- compositions
- cell
- bean
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ZZIALNLLNHEQPJ-UHFFFAOYSA-N coumestrol Chemical compound C1=C(O)C=CC2=C1OC(=O)C1=C2OC2=CC(O)=CC=C12 ZZIALNLLNHEQPJ-UHFFFAOYSA-N 0.000 title claims abstract description 191
- 239000000203 mixture Substances 0.000 title claims abstract description 92
- 239000002537 cosmetic Substances 0.000 title claims abstract description 14
- 229940069765 bean extract Drugs 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 claims description 33
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 5
- 230000002087 whitening effect Effects 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 description 55
- 210000004027 cell Anatomy 0.000 description 36
- 230000000694 effects Effects 0.000 description 32
- 244000046052 Phaseolus vulgaris Species 0.000 description 27
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 27
- 238000012360 testing method Methods 0.000 description 24
- 239000001963 growth medium Substances 0.000 description 17
- 230000002401 inhibitory effect Effects 0.000 description 17
- 239000000463 material Substances 0.000 description 12
- 210000004927 skin cell Anatomy 0.000 description 11
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 10
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 10
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 10
- 229960002986 dinoprostone Drugs 0.000 description 10
- 239000002552 dosage form Substances 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 10
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 9
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 230000037303 wrinkles Effects 0.000 description 9
- 229920001436 collagen Polymers 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 230000009759 skin aging Effects 0.000 description 8
- 230000037394 skin elasticity Effects 0.000 description 8
- 201000004624 Dermatitis Diseases 0.000 description 7
- 206010012438 Dermatitis atopic Diseases 0.000 description 7
- 201000008937 atopic dermatitis Diseases 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- HHZQLQREDATOBM-CODXZCKSSA-M Hydrocortisone Sodium Succinate Chemical compound [Na+].O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)COC(=O)CCC([O-])=O)[C@@H]4[C@@H]3CCC2=C1 HHZQLQREDATOBM-CODXZCKSSA-M 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 6
- 210000000582 semen Anatomy 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- -1 blocker Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 206010027654 Allergic conditions Diseases 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 210000004748 cultured cell Anatomy 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XDFNWJDGWJVGGN-UHFFFAOYSA-N 2-(2,7-dichloro-3,6-dihydroxy-9h-xanthen-9-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC(Cl)=C(O)C=C2OC2=CC(O)=C(Cl)C=C21 XDFNWJDGWJVGGN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 240000006677 Vicia faba Species 0.000 description 2
- 235000010749 Vicia faba Nutrition 0.000 description 2
- 235000002098 Vicia faba var. major Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000036252 glycation Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical class OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 1
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 102000009016 Cholera Toxin Human genes 0.000 description 1
- 108010049048 Cholera Toxin Proteins 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 206010067572 Oestrogenic effect Diseases 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 229930016834 coumestan Natural products 0.000 description 1
- JBIZUYWOIKFETJ-UHFFFAOYSA-N coumestan Chemical compound O1C2=CC=CC=C2C2=C1C(C=CC=C1)=C1OC2=O JBIZUYWOIKFETJ-UHFFFAOYSA-N 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005987 sulfurization reaction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Cosmetics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
Abstract
本发明涉及一种用于皮肤护理的化妆品组合物,该组合物含有香豆雌酚,或含有包含香豆雌酚的豆提取物。
Description
技术领域
本发明涉及一种皮肤护理组合物,该皮肤护理组合物含有香豆雌酚(Coumestrol),或者含有包含香豆雌酚的豆提取物。
背景技术
随着人类平均寿命的增加,如何长时间保持年轻比如何长时间生存更重要。随着人的年龄增长,老化是一个不可避免的过程。特别是,由于现代社会环境污染和压力越来越严重以及紫外线暴露的增加,老化会开始得比之前要早。
所有人体器官逐渐老化,且皮肤老化受外部环境的影响特别大。绝大多数早期的皮肤老化都始自皮肤干燥。当皮肤变得干燥时,它会失去弹性,且会变得容易产生皱纹。皮肤老化后,皮肤的再生需要很长时间,由于角质化皮肤会变得粗糙,因为胶原合成的减少产生皱纹。由于紫外线防御的减少产生雀斑、活斑等色素沉着,因为皮肤保护的减弱,皮肤变得易受药物或外部环境刺激的攻击。
发明内容
技术问题
本发明旨在提供一种含有作为活性成分的香豆雌酚,或包含香豆雌酚的豆提取物的皮肤护理组合物。
本发明还旨在提供一种作为化妆品组合物的皮肤护理组合物,其含有作为活性成分的香豆雌酚或包含香豆雌酚的豆提取物。
技术方案
一方面,本发明提供一种含有作为活性成分的香豆雌酚或包含香豆雌酚的豆提取物的皮肤护理组合物。
技术效果
本发明的所述皮肤护理组合物提供改善皮肤弹性、改善皮肤皱纹、美白皮肤、滋润皮肤、消炎、抗菌、防止皮肤老化、抗氧化、改善痤疮、改善特应性皮炎、缓解皮肤刺激、维持皮肤平衡和缓解或改善皮肤过敏的效果,其广泛应用于如化妆品或食品领域。
具体实施方式
这里使用的术语“提取物”指从天然物质中提取出来的物质,无论提取方法或成分。使用术语广义的含义,包括,例如水溶性成分或使用溶剂从天然物质中提取的有机溶剂或天然物质中的特定成分,如其中提取的油。
这里使用的术语“皮肤”指覆盖在动物身体表面的组织,使用广泛涵义,不仅包括覆盖面部或身体的组织,还包括头皮和毛发。
这里使用的术语“皮肤护理”包括改善皮肤外观和皮肤健康状况的任何治疗或护理。
接下来将详细描述本发明。
一方面,本发明提供一种含有作为活性成分的香豆雌酚、或包含香豆雌酚的豆提取物的皮肤护理组合物。
香豆雌酚(CMS;3,9-二羟基-6H-苯并呋喃(3,2-c)(1)苯并吡喃-6-酮)具有化学式1的结构。
化学式 1
香豆雌酚是一种植物***,一般可在豆科或菊科植物的种子、根或叶子中发现。它可被归为coumestan类异黄酮,已知其具有***的作用。
在本发明的一个典型实施例中,所述皮肤护理组合物包括香豆雌酚、含有香豆雌酚的天然物质或其提取物。在本发明的另一个典型实施例中,含有香豆雌酚的天然物质可以是选自大豆、豌豆、绿豆和从这些豆发出的豆芽、红三叶草(苜蓿)、抱子甘蓝或类似物中的一种或多种豆。在本发明的另一个典型实施例中,含有香豆雌酚的天然物质可以是豆。
在本发明的一个典型实施例中,所述豆可以为含有香豆雌酚的任何豆科植物,且没有特别的限制。例如,本发明所用的豆可以为用于豆瓣酱、豆腐、豆芽、豆米混合物或未成熟的豆的豆。用于豆瓣酱或豆腐的豆的品种包括大丰、湖酱、状元、大黄、小胆、松鹤、大元、真品、蛋白、豆油、新八达、太光、万里、长寿、无限、白云、鸟卵、黄金和长叶。用于豆芽的豆的品种包括神话、小圆、安平、西南、多彩、小绿、小湖、疏明、多元、丰产豆芽、益山豆芽、小白豆芽、光安、短叶和银河。用于豆米混合物的豆的品种包括青磁、黑青、褐味、鲜黑、黑豆和一品黑豆。此外,用于未成熟的豆的豆的品种包括多兀、新绿、新乙、黑乙、夕凉未熟豆、华严未熟豆和大乙。在本发明的另一个实施例中,所述豆可以为能够发芽且对疾病和害虫的侵害有抵抗力的豆。例如,所述豆的品种包括如神话、小圆、安平、西南、多彩、小绿、小湖、疏明、多元、丰产豆芽、益山豆芽、小白豆芽、光安、短叶和银河。
在本发明的一个典型实施例中,天然物质及其提取物可含有大量的香豆雌酚。具体地,香豆雌酚可以占所述天然物质或其提取物总重量的0.01-50wt%,更特别是0.1-30wt%。
在本发明的一个典型实施例中,在正常温度或高温条件下,用水或乙醇提取含有香豆雌酚的天然物质,完全浓缩产生的提取物,再次用水分散,用等体积的选自己烷、 二氯甲烷、 氯仿、 乙酸乙酯、 丁醇、 乙醇、 甲醇和水中的一种或多种溶剂进行分馏来获得含有所述香豆雌酚的天然物质的提取物。但是,提取方法并不仅限于此,可以使用任何其它的提取方法。
在本发明的一个典型实施例中,所述皮肤护理组合物可以是用于改善皮肤弹性或皱纹的皮肤护理组合物。组合物中含有作为活性成分的香豆雌酚,其会抑制作为胶原酶的基质金属蛋白酶-1(MMP-1)的表达,促进Ⅰ型pN-胶原蛋白的合成、抑制皮肤细胞的糖化、促进细胞中ATP的产生。含有作为活性成分的香豆雌酚的所述组合物,通过这些行为,可提供改善皮肤弹性和皱纹的更好的作用。具体地,所述组合物对改善紫外线引起的皮肤皱纹具有优越的作用。
在本发明的一个典型实施例中,所述皮肤护理组合物可以是用于美白皮肤的组合物。所述组合物中含有的、作为活性成分的香豆雌酚,能明显清除由于皮肤老化或紫外辐照产生的活性氧,抑制黑色素的产生,减少皮肤细胞的糖化。通过这些活动,含有作为活性成分的香豆雌酚的所述组合物可提供优越的皮肤美白作用。
在本发明的一个典型实施例中,所述皮肤护理组合物可以是用于滋润皮肤的组合物。所述组合物中含有的作为活性成分的香豆雌酚,减少皮肤中水分的消耗,通过促进细胞中ATP的合成,对皮肤的再生具有极佳的能力。通过这些活动,所述含有作为活性成分的香豆雌酚的组合物香豆雌酚可提供极佳的皮肤滋润作用。
在本发明的一个典型实施例中,所述皮肤护理组合物可以是消炎和抗菌组合物。所述组合物中含有的作为活性成分的香豆雌酚,抑制***素E2(PGE2)的生成,促进细胞中ATP的合成,通过抑制脂多糖类(LPS)引起的环氧合酶-2(COX-2)的生物合成,来抑制炎症反应,保护皮肤免受微生物或细菌的影响。通过这些活动,含有作为活性成分的香豆雌酚的所述组合物可提供极佳的消炎和抗菌作用。
在本发明的一个典型实施例中,所述皮肤护理组合物可以是用于防止皮肤老化的组合物或用于抗氧化的组合物。随着年龄的增加,胶原蛋白、弹性蛋白、透明质酸和糖蛋白的含量和排列方式会发生变化或减少。同时,皮肤会受到自由基或活性氧的氧化应激。所述组合物中含有的作为活性成分的香豆雌酚对清除活性氧,改善皮肤弹性和皮肤皱纹有极佳的作用,且具有更好的皮肤美白和皮肤滋润作用,并通过促进皮肤细胞的能量代谢,提供极佳的抑制皮肤老化或氧化的作用。通过这些活动,含有作为活性成分的香豆雌酚的所述组合物可提供防止皮肤老化或氧化的极佳效果。
在本发明的一个典型实施例中,所述皮肤护理组合物可以是用于改善痤疮的组合物。所述组合物中含有的作为活性成分的香豆雌酚,抑制PGE2的生成,控制皮脂和通过抑制LPS引起的COX-2的生物合成,来抑制炎症反应,从而提供改善痤疮和皮肤问题的效果。通过这些活动,含有作为活性成分的香豆雌酚的所述组合物可提供改善痤疮的作用。
在本发明的一个典型实施例中,所述皮肤护理组合物可以是改善特应性皮炎的组合物。因为组合物中含有的作为活性成分的香豆雌酚具有极佳的皮肤滋润、消炎和抗菌作用,以及极好的皮肤细胞再生能力,所以它能改善特应性皮炎。
在本发明的一个典型实施例中,所述皮肤护理组合物可以是减轻皮肤过敏或维持皮肤平衡的组合物。所述组合物中含有的作为活性成分的香豆雌酚抑制PGE2的生成,通过抑制LPS引起的COX-2的生物合成,来抑制炎症反应,从而提供防止皮肤炎症和外界有害物质引起的损坏的作用。通过这些活动,含有作为活性成分的香豆雌酚的所述组合物可以通过减轻因化学品、大气污染、紫外线等有害的外部因素引起的皮肤刺激来保护皮肤以及维持皮肤平衡的作用。
在本发明的一个典型实施例中,所述皮肤护理组合物可以是减轻或防止皮肤过敏的组合物。所述组合物中含有的作为活性成分的香豆雌酚具有更好的皮肤滋润、消炎和抗菌作用以及极佳的皮肤细胞再生作用。因此,含有作为活性成分的香豆雌酚的所述组合物可具有缓解或防止皮肤过敏的作用。
根据本发明的一个实施例,所述组合物可含有占所述组合物总重量的0.001-30wt%,优选0.01-10wt%,更优选0.1-5wt%的香豆雌酚或含有香豆雌酚的豆提取物。当香豆雌酚或含有香豆雌酚的豆提取物在上述范围内时,可充分实现本发明的预期效果,而稳定性和安全性均令人满意,且可实现有利的成本效益。
根据本发明的一个实施例,所述皮肤护理组合物可以是化妆品组合物。所述化妆品组合物可含有美容产品或皮肤允许的介质或碱。它可被制成任何局部应用形式,例如溶液、凝胶、粉体、膏、无水浆液、水包油型乳液、油包水型乳液、多重乳液(multiemulsion)、悬浮液、微乳剂、微胶囊、微粒、离子(脂质体)或非离子型的泡状分散体、泡沫或含有加压推进剂的气溶胶组合物。这些组合物可通过现有技术中通常采用的方法制备。
所述化妆品组合物还可以包括脂类物质、有机溶剂、增溶剂、增稠剂、凝胶剂、柔软剂、抗氧化剂、悬浮剂、稳定剂、发泡剂、芳香剂、表面活性剂、水、离子乳化剂或非离子乳化剂、填充剂、多价螯合剂、螯合剂、防腐剂、维生素、阻断剂、保湿剂、精油、染料、颜料、亲水性或疏水性活性剂、脂质囊泡或化妆品或皮肤学领域通常使用的其它佐剂。这些佐剂的添加量是化妆品或皮肤病学领域的常用量。
所述化妆品组合物并不具体限于提及的剂型,可根据用途选择合适的剂型。例如,所述化妆品组合物可被制备为选自化妆水、乳液、精华、乳霜、软膏、凝胶剂、面膜、贴片、喷雾剂、粉底、乳液底粉、遮瑕棒、手部或足部乳液、手部或足部乳霜、手部或足部油、手部或足部精华、手部或足部清洁剂、肥皂、清洁霜、清洁洗剂、清洁泡沫和清洁水中的一种或多种剂型,但并不仅限于此。
根据本发明的一个实施例,所述皮肤护理组合物可以是食品组合物。所述食品组合物可被制成例如片剂、颗粒剂、饮剂、焦糖等,但并不仅限于此。除了活性成分,所述食品组合物的每种剂型还可包括本领域常用的成分。根据使用用途,本领域的技术人员可毫无困难地选择所述成分,且所述成分可提供协同效应。
本领域的技术人员能确定所述活性成分的剂量。例如,该剂量可以是0.1-5000 mg/kg/天,优选50-500mg/kg/天,但并不仅限于此,且该剂量可因治疗对象的年龄、生理条件、并发症等因素的不同而有变化。
将通过测试实施例对本发明的特征和作用进行详细描述。但是,以下测试实施例仅用作说明用途,并非为了限制本发明的范围。
[测试实施例1] 对UVB-诱导的活性氧自由基(ROS)的清除作用的评价
用2’,7’-二氯二氢荧光素二乙酯(DCFH-DA,Molecular Probes公司,俄勒冈州,美国)来评价香豆雌酚对UVB-诱导的活性氧自由基(ROS)的清除作用。DCFH-DA是一种脂溶性物质,已知作为细胞中ROS的检测剂。它能很容易被细胞吸收,并在细胞中酯酶的作用下,发生乙酸酯基团的水解,转化成2’,7’-二氯二氢荧光素。由于2’,7’-二氯二氢荧光素与细胞内的氧化剂反应后转化成发出荧光的2’,7’-二氯荧光素(DCF),所以可通过测定用DCFH-DA处理的细胞的荧光强度来评价细胞内ROS的数量。
将角蛋白细胞(从德国癌症研究中心的Fusenig博士处获得)接种到96孔黑色板(Greiner BioOne公司,北卡罗莱纳州,美国)上用于荧光测试,密度为每孔1x104个细胞,培养24小时。接着,用在新鲜的无FBS的培养基中的、稀释至最终浓度为0.01、0.1或1μM的香豆雌酚处理所述细胞。加入测试物质后,培养细胞24小时。在用HEPES缓冲盐溶液(HCSS)冲洗去除剩余的培养基之后,加入DCFH-DA和HCSS混合液(DCFH-DA:20μM,HCSS:100μL)。将所述细胞在37℃和5%CO2条件下,培养20分钟后,用HCSS冲洗细胞。接着,加入100μL 的HCSS,用30mJ/cm2的UVB辐照细胞,以诱导产生ROS。随后,用在HCSS中稀释至相同浓度的香豆雌酚,在37℃和5%CO2条件下,培养细胞3小时。香豆雌酚用Wallac VICTOR2荧光计(Wallac,土尔库,芬兰)在激发波长485nm和发射波长530nm的条件下,测定DCF的荧光强度。通过测定的荧光强度,计算相对于对照组的ROS清除作用(%)。结果见表1。
[表 1]
由表1可以看出,香豆雌酚具有清除UVB-诱导的ROS的作用,其作用随着香豆雌酚浓度的增加而增加。因此,含有香豆雌酚的组合物可提供抑制由UV引起的皮肤氧化,抑制光老化和美白皮肤的作用。
[测试实施例2] 对UV-诱导的MMP-1表达的抑制作用的评价
用人体成纤维细胞(CAS-C-004-5C,Invitrogen,加利福尼亚州,美国)来评价香豆雌酚对UV-诱导的MMP-1表达的抑制作用。将细胞接种到24孔板,密度为每孔1x104个细胞,在含有10%FBS的培养基中培养约24小时,直至约80%的铺满。用无FBS的培养基替代之前的培养基之后,培养细胞24小时。用PBS冲洗1次后,加入100μL PBS,用15 mJ/cm2的UVB辐照细胞。去除PBS后,用在新鲜的无FBS的培养基中的、稀释至最终浓度为0.01,0.1或1μM的香豆雌酚处理细胞。用测试物质处理48小时后,评价MMP-1的表达。从细胞培养物中收集上清液后,用酶联免疫吸附测定(ELISA)试剂盒(RPN 2610,Biotrak Amersham Pharmacia Biotech,英国)来评价MMP-1的表达。通过总蛋白量来测定MMP-1的数量。计算MMP-1的活性(%),结果见表2。
[表 2]
由表2可以看出,香豆雌酚具有抑制UV-诱导的MMP-1活性的能力,且该能力随着香豆雌酚浓度的增加而增强。因此,含有香豆雌酚的组合物,可通过抑制胶原蛋白的损坏,来改善皮肤弹性和皱纹。
[测试实施例3] 对I型pN-胶原蛋白合成的效果评价
用人体成纤维细胞(CAS-C-004-5C,Invitrogen,加利福尼亚州,美国)来评价香豆雌酚对I型pN-胶原蛋白的合成作用。将细胞接种到24孔板,密度为每孔1x104个细胞,在含有10%FBS的培养基中培养约24小时,直至约80%的铺满。用在新鲜的无FBS的培养基中的、稀释至最终浓度为0.01,0.1或1μM的香豆雌酚处理所述细胞。在用测试物质处理48小时之后,从细胞培养物中收集上清液,用IC型前胶原-缩氨酸(PIP)EIA试剂盒(MK 101,Takara Shuzo,京都,日本)来测定I型pN-胶原蛋白的合成数量。通过总蛋白量来测定I型pN-胶原蛋白的数量。计算I型pN-胶原蛋白的合成数量,结果见表3。
[表 3]
由表3可以看出,香豆雌酚促进了I型pN-胶原蛋白的合成。因此,含有香豆雌酚的组合物可改善皮肤弹性和皱纹。
[测试实施例4] 对皮肤细胞糖化的抑制作用的评价
用人体成纤维细胞(CAS-C-004-5C,Invitrogen,加利福尼亚州,美国)来评价香豆雌酚对皮肤细胞糖化的抑制作用。将细胞接种到6孔板,密度为每孔5x104个细胞,在含有10%FBS的培养基中培养约24小时,直至约80%的铺满。用PBS冲洗1次后,加入100μL PBS,用50mJ/cm2的UVB辐照细胞。去除PBS后,用在新鲜的无FBS的培养基中的、稀释至最终浓度为2.5μM的香豆雌酚处理所述细胞。用测试物质处理24小时后,用OxiselectTM高级糖化终产物(AGE)ELISA试剂盒来评价皮肤细胞的糖化。测定糖化终产物的浓度,如表4所示。
[表 4]
由表4可以看出,香豆雌酚抑制了皮肤细胞的糖化。因此,含有香豆雌酚的组合物可改善皮肤弹性和提供美白皮肤的作用。
[测试实施例5] ATP生成作用的评价
在对人体成纤维细胞(CAS-C-004-5C,Invitrogen,科罗拉多州,美国)进行测试实施例4的处理之后,用ATP测定试剂盒(Invitrogen,A22066)评价细胞中ATP的生成。测定的ATP的浓度如表5所示。
[表 5]
由表5可以看出,香豆雌酚促进了细胞中ATP的产生。因此,含有香豆雌酚的组合物可促进皮肤再生,通过促进皮肤细胞的能量代谢改善皮肤弹性和活化皮肤细胞。
[测试实施例6] 对黑色素生成的抑制作用的评价
将取自C57BL/6小鼠的小鼠黑素细胞(Mel-Ab细胞),在37℃和5%的CO2中,含有10%FBS、100nM 2-氧-十四烷酰佛波醇-13-乙酸酯(2-O-tetradecanoylphorbol-13-acetate)和1 nM霍乱毒素的Dulbecco改良的Eagles培养基(DMEM)中培养。用0.25%胰蛋白酶-EDTA分离培养后的Mel-Ab细胞,并在24-孔板上培养,每孔105个细胞。从第二天开始,连续3天加入0.01、0.1或1μM的香豆雌酚。接着,去除培养基后,用PBS冲洗,将细胞悬浮在1N的氢氧化钠中,测定400nm处的吸光度。用10μM的对苯二酚作为阳性对照组,已知其具有卓越的黑色素的生成抑制作用。根据测定的吸光度计算黑色素生成抑制作用(%),结果见表6。
[表 6]
由表6可以看出,香豆雌酚具有极佳的黑色素生成抑制作用。因此,含有香豆雌酚的组合物可具有卓越的皮肤美白作用。
[测试实施例7] 对***素E2(PGE2)生成的抑制作用的评价
按如下方法测试香豆雌酚对***素E2生成的抑制作用。将人体成纤维细胞(CAS-C-004-5C,Invitrogen,加利福尼亚州,美国)在CO2培养箱中培养24小时。用新鲜的无FBS的培养基替换培养基之后,培养2小时,然后用在新鲜的无FBS的培养基中的、稀释至最终浓度为0.01,0.1或1μM的香豆雌酚处理细胞。然后将细胞在并在37℃和5%(体积比)CO2培养箱中培养2小时。接着,用50μM的钙离子载体A23187和花生四烯酸处理细胞5分钟以刺激***素E2,细胞裂解,用ELISA读数器测定450nm处的吸光度来定量***素E2,结果见表7。计算相对于未经香豆雌酚处理组的抑制作用(%)。测定5次,结果取平均值。
[表 7]
由表7可知,香豆雌酚可抑制***素E2的生成。因此,含有香豆雌酚的组合物具有消炎作用,可防止皮脂分泌、缓解皮肤问题、改善痤疮和皮肤过敏。
[测试实施例8] 对脂多糖类(LPS)诱导的环氧合酶-2(COX-2)生物合成的抑制作用的评价
用人体成纤维细胞(CAS-C-004-5C,Invitrogen,加利福尼亚州,美国)评价香豆雌酚对COX-2生物合成的抑制作用。将细胞接种到6孔板,密度为每孔5x104个细胞,在含有10%FBS的培养基中培养约24小时,直至约80%铺满(80% confluency)。用在新鲜的无FBS的培养基中的、稀释至最终浓度为0.01,0.1或1μM的香豆雌酚处理细胞,然后在37℃和5%(体积比)CO2培养箱中培养24小时。收获细胞,并用蛋白质印迹法对产生的COX-2进行定量。计算相对于对照组的COX-2表达水平(%),结果见表8。
[表 8]
由表8可知,香豆雌酚抑制了LPS诱导的COX-2的生物合成。因此,含有香豆雌酚的组合物可提供消炎作用,改善痤疮和皮肤过敏。
[测试实施例9] 对特应性皮炎的改善作用的评价
将诊断为具有过敏性症状(发痒、水疱或严重的干燥)或表现出遗传性过敏症状的10岁-50岁的30人分成2组,分别给予含有0.1%香豆雌酚的软膏或不含香豆雌酚的软膏(对照组)。要求他们在其过敏性症状的部位涂敷上述软膏连续12周,每天两次。12周后,通过调查问卷检验过敏性症状的改善。检查到特应性皮炎的典型症状包括“发痒”、“干燥”、“角质化”、“头皮屑”、“红斑”、“肿胀”、“皮肤裂”、“分泌物和湿疹”的改善。让受试者为症状的改善情况打分,取平均值来评价特应性皮炎的改善,结果见表9。
[表 9]
由表9可以看出,香豆雌酚和含有香豆雌酚的组合物具有改善特应性皮炎的作用。
[测试实施例10] 对皮肤保湿的改善作用的评价
为了评价皮肤保湿能力的改善,在恒温、恒湿(24℃,相对湿度40%)条件下,用皮肤水分测试仪测定测试实施例9中受试者的经皮水分损失,结果取平均值,见表10。
[表 10]
由表10可以看出,香豆雌酚能抑制经皮水分的损失,且随着时间的延长,抑制作用会增加。因此,含有香豆雌酚的组合物可提供皮肤保湿的作用。
下面将描述本发明组合物的剂型实施例,但是本发明的范围并不仅局限于以下实施例。
[剂型实施例1] 柔肤乳液
根据通常采用的方法,用表11中描述的成分制备柔肤乳液。
[表 11]
[剂型实施例2] 滋养乳液
根据通常采用的方法,用表12中描述的成分制备滋养乳液。
[表 12]
[剂型实施例3] 滋养霜
根据通常采用的方法,用表13中描述的成分制备滋养霜。
[表13]
[剂型实施例4] 片剂
将香豆雌酚(80mg)、维生素E(9mg)、维生素C(9mg)、低聚半乳糖(200mg)、乳糖(60mg)和麦芽糖(140mg)混合,用硫化干燥床造粒。加入糖酯(6mg)后,根据通常采用的方法,将所得的组合物(500mg)制备成片剂。
[剂型实施例5] 饮剂
将香豆雌酚(80mg)、维生素E(9mg)、维生素C(9mg)、葡萄糖(10g)、柠檬酸(0.6g)和寡糖糖浆(25g)混合。加入纯净水(300mL)后,将200mL所得混合物填充到瓶中。接着,在130℃消毒4-5秒便制成饮剂。
本领域的技术人员可以理解在本发明的范围内,可对本发明进行各种更改或修改。
Claims (5)
1.香豆雌酚或者包含香豆雌酚的豆提取物在制备用于美白皮肤的皮肤护理组合物中的应用。
2.根据权利要求1所述的应用,其特征在于,所述组合物能够抑制黑色素生成。
3.根据权利要求1所述的应用,其特征在于,所述组合物含有占所述组合物总重量的0.001-30wt%的香豆雌酚或含有香豆雌酚的豆提取物。
4.根据权利要求1-3任一项所述的应用,其特征在于,所述组合物为化妆品组合物。
5.根据权利要求1-3任一项所述的应用,其特征在于,所述组合物为食品组合物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20100029164 | 2010-03-31 | ||
KR10-2010-0029164 | 2010-03-31 | ||
CN2011800263374A CN102905685A (zh) | 2010-03-31 | 2011-03-31 | 含有香豆雌酚或包含香豆雌酚的豆提取物的、用于皮肤护理的化妆品组合物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011800263374A Division CN102905685A (zh) | 2010-03-31 | 2011-03-31 | 含有香豆雌酚或包含香豆雌酚的豆提取物的、用于皮肤护理的化妆品组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103989589A true CN103989589A (zh) | 2014-08-20 |
CN103989589B CN103989589B (zh) | 2018-08-21 |
Family
ID=44720419
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410243191.4A Active CN103989589B (zh) | 2010-03-31 | 2011-03-31 | 含有香豆雌酚或包含香豆雌酚的豆提取物的、用于皮肤护理的化妆品组合物 |
CN201510909598.0A Pending CN105362151A (zh) | 2010-03-31 | 2011-03-31 | 含有香豆雌酚或包含香豆雌酚的豆提取物的、用于皮肤护理的化妆品组合物 |
CN2011800263374A Pending CN102905685A (zh) | 2010-03-31 | 2011-03-31 | 含有香豆雌酚或包含香豆雌酚的豆提取物的、用于皮肤护理的化妆品组合物 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510909598.0A Pending CN105362151A (zh) | 2010-03-31 | 2011-03-31 | 含有香豆雌酚或包含香豆雌酚的豆提取物的、用于皮肤护理的化妆品组合物 |
CN2011800263374A Pending CN102905685A (zh) | 2010-03-31 | 2011-03-31 | 含有香豆雌酚或包含香豆雌酚的豆提取物的、用于皮肤护理的化妆品组合物 |
Country Status (4)
Country | Link |
---|---|
US (1) | US9265707B2 (zh) |
KR (3) | KR20110110052A (zh) |
CN (3) | CN103989589B (zh) |
WO (1) | WO2011122869A2 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101854158B1 (ko) * | 2011-10-24 | 2018-06-14 | (주)아모레퍼시픽 | 콩꽃 추출물을 함유하는 피부 외용제 조성물 |
KR102063686B1 (ko) * | 2012-01-02 | 2020-02-11 | (주)아모레퍼시픽 | 콩뿌리 추출물을 함유하는 피부 외용제 조성물 |
KR102033448B1 (ko) * | 2012-07-31 | 2019-10-17 | (주)아모레퍼시픽 | 콩뿌리 추출물을 포함하는 항염증용 조성물 |
KR102014960B1 (ko) * | 2012-07-31 | 2019-08-28 | (주)아모레퍼시픽 | 콩뿌리 추출물을 함유하는 항산화용 조성물 |
KR101957845B1 (ko) * | 2012-07-31 | 2019-03-14 | (주)아모레퍼시픽 | 콩뿌리 추출물을 포함하는 모발 및 두피 상태 개선용 조성물 |
KR102014962B1 (ko) * | 2012-08-02 | 2019-08-28 | (주)아모레퍼시픽 | 콩꼬투리 추출물을 포함하는 항염증용 조성물 |
KR101985356B1 (ko) * | 2012-08-03 | 2019-06-04 | (주)아모레퍼시픽 | 발효콩 추출물을 함유하는 피부 외용제 조성물 |
KR101989067B1 (ko) * | 2013-02-28 | 2019-06-14 | (주)아모레퍼시픽 | 쿠메스트린을 함유하는 조성물 |
KR102200014B1 (ko) * | 2013-05-06 | 2021-01-08 | (주)아모레퍼시픽 | 쿠메스트롤을 포함하는 콩 추출물을 유효성분으로 포함하는 갱년기 증상의 예방 및 치료용 조성물 |
WO2015018631A1 (en) * | 2013-08-09 | 2015-02-12 | Unilever N.V. | Skin care composition |
FR3015526B1 (fr) * | 2013-12-20 | 2017-02-17 | Oreal | Biomarqueur npy1r du lentigo actinique |
US9730972B1 (en) * | 2016-06-13 | 2017-08-15 | Ashley Diana Black International Holdings, Llc | Skin tightening lotion |
US20190134129A1 (en) | 2017-11-06 | 2019-05-09 | Sinotai Oncology Associate., Ltd. | Method for alleviating ultraviolet damage with ethyl acetate-extracted product of sedum formosanum |
KR102226151B1 (ko) * | 2017-11-20 | 2021-03-11 | (주)아모레퍼시픽 | 콩과식물 배양근을 이용한 쿠메스트롤 생산 방법 |
KR20200040583A (ko) * | 2018-10-10 | 2020-04-20 | (주)아모레퍼시픽 | 코티존 환원효소 저해용 조성물 |
KR102249711B1 (ko) * | 2018-10-23 | 2021-05-10 | (주)아모레퍼시픽 | 콩과 식물 배양근의 효소 처리 추출물을 함유하는 피부 탄력 증진용 또는 피부 주름 개선용 조성물 |
KR101997033B1 (ko) * | 2018-11-19 | 2019-07-08 | (주)아모레퍼시픽 | 콩뿌리 추출물을 포함하는 항염증용 조성물 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06321763A (ja) * | 1993-05-17 | 1994-11-22 | Kao Corp | 美白剤 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2324060A1 (en) * | 1998-03-30 | 1999-10-07 | The Regents Of The University Of California | Methods and compounds for modulating nuclear receptor activity |
KR100338654B1 (ko) * | 2000-06-23 | 2002-05-30 | 임병철 | 페룰산에스테르 유도체, 3,9-디페룰릴쿠메스트롤 및 이를함유한 화장료 |
KR100628518B1 (ko) | 2003-06-12 | 2006-09-26 | 김홍렬 | 대두황권 추출물 및 이를 함유하는 피부노화 방지용기능성 화장품 |
FR2863886B1 (fr) * | 2003-12-22 | 2007-05-04 | Oreal | Utilisation d'un ligand steroidien ou non-steroidien du recepteur ecr dans une preparation cosmetique ou dermatologique pour maintenir l'homeostasie cutanee. |
EP1748767B1 (en) * | 2004-05-28 | 2011-12-28 | Unigen, Inc. | 1-(3-methyl-2,4-dimethoxyphenyl)-3-(2',4'-dihydroxyphenyl)-propane as a potent tyrosinase inhibitor |
KR20080018624A (ko) * | 2006-08-25 | 2008-02-28 | 제노마인(주) | 유기 셀레늄이 강화된 발아콩 추출물의 용도 |
US9101161B2 (en) * | 2006-11-02 | 2015-08-11 | The Coca-Cola Company | High-potency sweetener composition with phytoestrogen and compositions sweetened therewith |
KR100902326B1 (ko) * | 2007-07-27 | 2009-06-12 | 주식회사 엘지생활건강 | 발아콩 추출물을 포함하는 조성물 |
-
2011
- 2011-03-31 CN CN201410243191.4A patent/CN103989589B/zh active Active
- 2011-03-31 US US13/637,959 patent/US9265707B2/en active Active
- 2011-03-31 KR KR1020110029582A patent/KR20110110052A/ko active Application Filing
- 2011-03-31 CN CN201510909598.0A patent/CN105362151A/zh active Pending
- 2011-03-31 CN CN2011800263374A patent/CN102905685A/zh active Pending
- 2011-03-31 WO PCT/KR2011/002218 patent/WO2011122869A2/ko active Application Filing
-
2014
- 2014-03-12 KR KR1020140028981A patent/KR20140040790A/ko active Application Filing
-
2015
- 2015-08-20 KR KR1020150117315A patent/KR101677254B1/ko active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06321763A (ja) * | 1993-05-17 | 1994-11-22 | Kao Corp | 美白剤 |
Also Published As
Publication number | Publication date |
---|---|
KR101677254B1 (ko) | 2016-11-17 |
KR20150101980A (ko) | 2015-09-04 |
CN102905685A (zh) | 2013-01-30 |
WO2011122869A3 (ko) | 2012-02-02 |
KR20140040790A (ko) | 2014-04-03 |
KR20110110052A (ko) | 2011-10-06 |
US9265707B2 (en) | 2016-02-23 |
US20130071342A1 (en) | 2013-03-21 |
CN105362151A (zh) | 2016-03-02 |
CN103989589B (zh) | 2018-08-21 |
WO2011122869A2 (ko) | 2011-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103989589B (zh) | 含有香豆雌酚或包含香豆雌酚的豆提取物的、用于皮肤护理的化妆品组合物 | |
TWI381834B (zh) | Abnormal protein removal composition | |
KR101059471B1 (ko) | 피부 노화 방지용 화장료 조성물 | |
KR101387308B1 (ko) | 황칠나무 발효산물을 이용한 피부 미백 화장료 조성물 | |
KR101176528B1 (ko) | 배암차즈기 추출물을 유효성분으로 함유하는 화장료 조성물 | |
JP5645344B2 (ja) | 外用剤組成物 | |
KR102063686B1 (ko) | 콩뿌리 추출물을 함유하는 피부 외용제 조성물 | |
JP5714956B2 (ja) | コラーゲン産生促進剤 | |
JP2023171950A (ja) | 抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料 | |
KR20130114502A (ko) | 산수유 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR101400264B1 (ko) | 진피 및 우슬의 혼합 추출물을 함유하는 피부장벽강화용 조성물 | |
US20200078290A1 (en) | Cosmetic Composition Comprising Extract Of Medicinal Herbs As Active Ingredient | |
KR101803757B1 (ko) | 생약재 복합 발효 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR20140025737A (ko) | 산성 이온수를 이용한 새싹 발효 추출물의 추출방법 및 이로써 얻어진 추출물을 포함하는 화장료 조성물 | |
KR101303807B1 (ko) | 항노화 화장료 조성물 | |
JP2012162487A (ja) | 美白剤、抗老化剤及び皮膚化粧料 | |
US20150104426A1 (en) | Skin-care agent containing pleurotus ferulae fruit body extract or pleurotus ferulae mycelium extract | |
KR101402753B1 (ko) | 불미나리 추출물 및 발효추출물을 함유하는 피부 화장료 | |
KR101207560B1 (ko) | 빗죽이나무 추출물을 유효성분으로 함유하는 화장료 조성물 | |
JP2013014627A (ja) | ヘパリン結合性上皮成長因子様成長因子(hb−egf)生成促進剤 | |
KR20140139447A (ko) | 진귤 과피 효소 처리물 또는 그것의 추출물을 이용한 화장품 조성물 | |
US20240091294A1 (en) | Extract of Top Growth of Holy Basil, and Cosmetic or Dermatological Compositions Containing Same | |
KR101207559B1 (ko) | 윤노리나무 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR20110032670A (ko) | 닥나무 속 식물의 캘러스를 함유하는 피부 개선 조성물 | |
KR20240080284A (ko) | 생열귀 및 연교 추출물을 함유하는 피부 장벽 강화 및 주름 개선용 조성물 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |